187 related articles for article (PubMed ID: 18958496)
41. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction.
Gelb BD; Tartaglia M
Hum Mol Genet; 2006 Oct; 15 Spec No 2():R220-6. PubMed ID: 16987887
[TBL] [Abstract][Full Text] [Related]
42. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
43. Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRAS genes.
Houweling AC; de Mooij YM; van der Burgt I; Yntema HG; Lachmeijer AM; Go AT
Prenat Diagn; 2010 Mar; 30(3):284-6. PubMed ID: 20112233
[No Abstract] [Full Text] [Related]
44. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
45. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
[TBL] [Abstract][Full Text] [Related]
46. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
[TBL] [Abstract][Full Text] [Related]
47. Expanding the genetic spectrum of Noonan syndrome.
Noordam K
Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
[TBL] [Abstract][Full Text] [Related]
48. Cardiovascular disease in Noonan syndrome.
Pierpont ME; Digilio MC
Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
[TBL] [Abstract][Full Text] [Related]
49. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
Carta C; Pantaleoni F; Bocchinfuso G; Stella L; Vasta I; Sarkozy A; Digilio C; Palleschi A; Pizzuti A; Grammatico P; Zampino G; Dallapiccola B; Gelb BD; Tartaglia M
Am J Hum Genet; 2006 Jul; 79(1):129-35. PubMed ID: 16773572
[TBL] [Abstract][Full Text] [Related]
50. Deregulated Ras signaling in developmental disorders: new tricks for an old dog.
Schubbert S; Bollag G; Shannon K
Curr Opin Genet Dev; 2007 Feb; 17(1):15-22. PubMed ID: 17208427
[TBL] [Abstract][Full Text] [Related]
51. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
52. Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.
Hung CS; Lin JL; Lee YJ; Lin SP; Chao MC; Lo FS
J Formos Med Assoc; 2007 Feb; 106(2):169-72. PubMed ID: 17339163
[TBL] [Abstract][Full Text] [Related]
53. Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.
Kratz CP; Schubbert S; Bollag G; Niemeyer CM; Shannon KM; Zenker M
Cell Cycle; 2006 Aug; 5(15):1607-11. PubMed ID: 16921267
[TBL] [Abstract][Full Text] [Related]
54. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.
Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ
Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340
[TBL] [Abstract][Full Text] [Related]
55. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
56. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
[TBL] [Abstract][Full Text] [Related]
57. Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes.
Tartaglia M; Cotter PD; Zampino G; Gelb BD; Rauen KA
Clin Genet; 2003 May; 63(5):423-6. PubMed ID: 12752577
[TBL] [Abstract][Full Text] [Related]
58. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations.
Gripp KW; Lin AE
Genet Med; 2012 Mar; 14(3):285-92. PubMed ID: 22261753
[TBL] [Abstract][Full Text] [Related]
59. [RIT1: a novel gene associated with Noonan syndrome].
Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
[TBL] [Abstract][Full Text] [Related]
60. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]